(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Latest News Releases From The Newsroom

Earnings Countdown: Tesla, ASML Holding, and Netflix Take Center Stage

October 14th, 2023

On Wednesday, October 18, the spotlight turns to these key companies as they prepare to unveil their financial results: Tesla, Inc. (Nasdaq: TSLA), the renowned electric vehicle manufacturer, is poised to post its financial results for the third q. Read more

S&P 500 Boosts Lululemon; Pfizer Lowers Profits, Revenue Outlook

October 13th, 2023

Lululemon Athletica Inc. (Nasdaq: LULU), a notable athletic apparel company, will replace Activision Blizzard Inc. (Nasdaq: ATVI) in the S&P 500 index, effective at the opening of trading on Wednesday, October 18. The S&P 500 is widely recognized . Read more

BlackRock Posts Mixed Q3 Earnings; Bullish View On Immunovant

October 13th, 2023

BlackRock, Inc. (NYSE: BLK), an investment management and financial services company, reported third-quarter 2023 adjusted earnings per share (EPS) of $10.91, surpassing the consensus EPS estimate of $8.26. However, the company's revenue for the peri. Read more

Bidenomics in Action: Biden-Harris Administration's Clean Hydrogen Vision Boosted By Regional Hubs

October 13th, 2023

President Biden and Energy Secretary Jennifer Granholm have unveiled a significant development in the drive for a clean energy economy: seven regional clean hydrogen hubs will receive $7 billion in funding from the Bipartisan Infrastructure Law.. Read more

Lockheed Martin Scores $379.5M+ Order; Belden Sees Q3 Below-Consensus

October 13th, 2023

Lockheed Martin Corporation (NYSE: LMT) secured a $379,577,128 firm-fixed-price order to produce and deliver eight MH-60R aircraft for the government of Spain. The contract was awarded through a previously issued basic ordering agreement, with Naval . Read more

Earnings Reaction Rollercoaster: Comtech Rises, T2 Biosystems Tumbles

October 12th, 2023

Comtech Telecommunications Corp. (Nasdaq: CMTL), a telecommunications company, posted fourth-quarter fiscal 2023 earnings of $0.29 per share, surpassing the consensus EPS estimate of $0.17. The company reported quarterly sales of $148.81 million, exc. Read more

Delta Air Lines Beats Estimates; Domino's Pizza Unveils Mixed Results

October 12th, 2023

Delta Air Lines, Inc. (NYSE: DAL) reported third-quarter 2023 earnings of $2.03 per share, beating the consensus EPS estimate of $1.94. The company's quarterly revenue amounted to $15.50 billion, exceeding analysts' projections of $14.54 billion in r. Read more

Breaking: Microsoft Faces IRS Demand for $28.9B in Tax Dispute

October 11th, 2023

In a regulatory filing with the U.S. Securities and Exchange Commission (SEC), Microsoft Corporation (Nasdaq: MSFT) disclosed that it has received Notices of Proposed Adjustment (NOPAs) from the Internal Revenue Service (IRS) for the tax years 2004 t. Read more

FTC Proposes Rule to Ban Junk Fees

October 11th, 2023

Proposed rule would prohibit hidden and falsely advertised fee Washington D.C. / CRWE PRESS RELEASE / October 11, 2023 -  The Federal Trade Commission today announced a new proposed rule to prohibit junk fees, which are hidden . Read more

Momentum: Tempest Therapeutics Rides High on TPST-1120 Clinical Data

October 11th, 2023

Shares of Tempest Therapeutics, Inc. (Nasdaq: TPST) surged by more than 400% in pre-market trading due to strong clinical results for TPST-1120 in the first-line treatment of patients with unresectable or metastatic hepatocellular carcinoma. In a . Read more